新型冠状病毒肺炎患者肝损伤机制研究进展  

Liver injuries in patients with corona virus disease 2019

作　　者：胡灵溪 崔坡(综述)[1] 王荣琦(审校)[1] Hu Lingxi;Cui Po;Wang Rongqi(Department of Traditional and Western Medicine on Liver Diseases,Hebei Key Laboratory of Liver Fibrosis Study,Third Hospital,Hebei Medical University,Shijiazhuang 050051,Hebei Province,China)

机构地区：[1]河北医科大学第三医院中西医结合肝病科/河北省慢性肝病肝纤维化机制研究重点实验室,石家庄市050051

出　　处：《实用肝脏病杂志》2022年第3期453-456,共4页Journal of Practical Hepatology

基　　金：河北省重点研发计划项目(编号:20277713D)。

摘　　要：目的由新型冠状病毒(SARS-CoV-2)引起的新型冠状病毒肺炎(COVID-19)疫情已引起世界范围的大流行。呼吸道被认为是SARS-CoV-2感染的主要靶器官。部分COVID-19患者会出现不同程度的肝损伤。本文对COVID-19相关肝损伤发生机制研究进展进行了综述,以期为该病的防治提供参考。Objective The pandemic of COVID-19 has ravaged all over the world.The respiratory tract is considered to be the main target of SARS-CoV-2 infection.Some COVID-19 patients have different degrees of liver injuries.We reviewed the progress on mechanism of liver injuries,so as to provide a therapeutic strategies for COVID-19 patients with liver injuries.

关 键 词：新型冠状病毒肺炎 新型冠状病毒 肝损伤 细胞因子风暴 

分 类 号：R563.1[医药卫生—呼吸系统] R575[医药卫生—内科学]